Global Biomarkers Market (2021-2026) by Type, Disease Indication, Application, Components, End User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

The Global Biomarkers Market is estimated to be USD 40.27 Bn in 2021 and is expected to reach USD 74.03 Bn by 2026, growing at a CAGR of 12. 95%.



Market Dynamics

The government projects and programs that support the health care sector have prompted the global biomarkers market. The increasing prevalence of diseases such as cancer, cardiovascular diseases, and neurological diseases and the growing demand for biomarkers treatment are majorly increasing the market growth. In addition, the vital role of Biomarkers in disease risk management, drug discovery & development, personalized medicine, disease diagnosis, etc., is further propelling the market growth. However, the need for high capital investment, unfavorable regulatory and settlement policies, and high R & D cost of R&D is anticipated to hinder the market growth.

Market Segmentation

The Global Biomarkers Market is segmented further based on Type, Disease Indication, Application, Components, End User, and Geography.

By Type, the market is classified into safety biomarkers, efficacy biomarkers, validation biomarkers. Amongst all, the safety biomarkers segment is estimated to hold the highest market share during the forecast period.

By Diseases Indication, the market is classified as cancer, cardiovascular disorders, neurological disorders, immunological disorders, and others. Amongst all, the cancer segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as diagnostics, drug discovery and development, personalized medicine, disease risk assessment, and others. Amongst all, the personalized medicine segment is estimated to hold the highest market share during the forecast period.

By Components, the market is classified as consumables, services, and software. Amongst all, the consumables segment is estimated to hold the highest market share during the forecast period.

By End User, the market is classified as pharmaceutical companies, CRO's, diagnostic centers, academic research institutes, and others. Amongst all, the pharmaceutical companies segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Amgen launches Biomarker Assist, a program to help more patients with metastatic non-small cell lung cancer gain access to biomarker testing - 19th April 2021
2. Biocartis announces new collaboration with AstraZeneca to expand the availability of Idylla™ EGFR biomarker testing among patients with lung cancer at selected hospital sites in Biocartis’ European and global distributor markets - 4th May 2021
3. Bio-Rad introduces reliance select cDNA synthesis kit, a reverse transcription solution that efficiently converts RNA to DNA. A more sensitive reverse transcription will help for the discovery of new biomarkers - 11th March 2020

Company Profiles

Some of the companies covered in this report are AstraZeneca, Qiagen N.V, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, PerkinElmer Inc, Merck Group, Bio-Rad Laboratories, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Biomarkers Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market